NOVONIX Files 6-K with Application for Quotation
Ticker: NVNXF · Form: 6-K · Filed: Jul 25, 2025 · CIK: 1859795
Sentiment: neutral
Topics: filing, regulatory
TL;DR
NOVONIX filed a 6-K with an Appendix 2A for quotation. Watch for trading updates.
AI Summary
NOVONIX Limited filed a Form 6-K on July 25, 2025, reporting its activities for the month of July 2025. The filing includes Exhibit 99.1, which is an Appendix 2A, an application for quotation. NOVONIX is incorporated in Australia and its principal executive office is located in Brisbane.
Why It Matters
This filing indicates a step in NOVONIX's process for listing or trading securities, potentially impacting its market visibility and investor access.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain significant financial or operational news.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- July 25, 2025 (date) — Filing Date
- Brisbane, QLD 4000 Australia (location) — Principal Executive Office
- Appendix 2A (document) — Included Exhibit
FAQ
What is the purpose of the Appendix 2A filed as Exhibit 99.1?
The Appendix 2A is an application for quotation, as indicated in the Exhibit Index of the Form 6-K.
What is NOVONIX Limited's fiscal year end?
NOVONIX Limited's fiscal year ends on December 31st.
Under which SEC Act is this Form 6-K filed?
This Form 6-K is filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the Commission File Number for NOVONIX Limited?
The Commission File Number for NOVONIX Limited is 001-41208.
Does NOVONIX file its annual reports under Form 20-F or Form 40-F?
NOVONIX indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 25, 2025 regarding NOVONIX Ltd (NVNXF).